160 related articles for article (PubMed ID: 37386069)
21. Relationship between menopausal hormone therapy and breast cancer: A nationwide population-based cohort study.
Yuk JS
Int J Gynaecol Obstet; 2024 Mar; ():. PubMed ID: 38469634
[TBL] [Abstract][Full Text] [Related]
22. Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women.
Kim H; Kang MJ; Baek JK; Lee JK; Choi EA; Yun BH; Kim EH; Seo SK
Climacteric; 2024 Apr; 27(2):165-170. PubMed ID: 37947171
[TBL] [Abstract][Full Text] [Related]
23. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.
Long MD; Martin CF; Pipkin CA; Herfarth HH; Sandler RS; Kappelman MD
Gastroenterology; 2012 Aug; 143(2):390-399.e1. PubMed ID: 22584081
[TBL] [Abstract][Full Text] [Related]
24. Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials.
Tang JY; Spaunhurst KM; Chlebowski RT; Wactawski-Wende J; Keiser E; Thomas F; Anderson ML; Zeitouni NC; Larson JC; Stefanick ML
J Natl Cancer Inst; 2011 Oct; 103(19):1469-75. PubMed ID: 21878677
[TBL] [Abstract][Full Text] [Related]
25. Association Between Menopausal Hormone Therapy and Risk for Parkinson's Disease.
Yuk JS; Jeong SH
J Parkinsons Dis; 2023; 13(8):1357-1367. PubMed ID: 37980684
[TBL] [Abstract][Full Text] [Related]
26. Effect of menopausal hormonal therapy on cardiovascular risks in Korean postmenopausal women: A nationwide cohort study.
Yuk JS; Kim GS; Byun YS; Yang SW; Kim MH; Yoon SH; Seo YS; Kim BG
BJOG; 2024 Mar; ():. PubMed ID: 38465460
[TBL] [Abstract][Full Text] [Related]
27. Risk of second cancers after the diagnosis of non-melanoma skin cancer in Korean patients.
Roh MR; Shin HJ; Lee SH; Chung KY
J Dermatol; 2012 Jun; 39(6):541-4. PubMed ID: 22380519
[TBL] [Abstract][Full Text] [Related]
28. Risk of skin cancer in patients with diabetes mellitus: A nationwide retrospective cohort study in Taiwan.
Tseng HW; Shiue YL; Tsai KW; Huang WC; Tang PL; Lam HC
Medicine (Baltimore); 2016 Jun; 95(26):e4070. PubMed ID: 27368048
[TBL] [Abstract][Full Text] [Related]
29. Menopausal hormone therapy and cancer risk: An overestimated risk?
Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
[TBL] [Abstract][Full Text] [Related]
30. Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?
Jones ME; Schoemaker MJ; Wright L; McFadden E; Griffin J; Thomas D; Hemming J; Wright K; Ashworth A; Swerdlow AJ
Br J Cancer; 2016 Aug; 115(5):607-15. PubMed ID: 27467055
[TBL] [Abstract][Full Text] [Related]
31. Menopause, hysterectomy, menopausal hormone therapy and cause-specific mortality: cohort study of UK Biobank participants.
Xu Z; Chung HF; Dobson AJ; Wilson LF; Hickey M; Mishra GD
Hum Reprod; 2022 Aug; 37(9):2175-2185. PubMed ID: 35690930
[TBL] [Abstract][Full Text] [Related]
32. Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.
Simin J; Liu Q; Wang X; Fall K; Williams C; Callens S; Engstrand L; Brusselaers N
Acta Oncol; 2021 Jul; 60(7):881-887. PubMed ID: 33861686
[TBL] [Abstract][Full Text] [Related]
33. Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort.
Abbas AM; Almukhtar RM; Loftus EV; Lichtenstein GR; Khan N
Am J Gastroenterol; 2014 Nov; 109(11):1781-93. PubMed ID: 25244964
[TBL] [Abstract][Full Text] [Related]
34. Menopausal hormone therapy and melanoma risk in the Australian longitudinal study on women's health.
Botteri E; Xu Z; Støer NC; Mishra GD
Maturitas; 2022 Jun; 160():1-3. PubMed ID: 35550702
[TBL] [Abstract][Full Text] [Related]
35. Exogenous hormone use and cutaneous melanoma risk in women: The European Prospective Investigation into Cancer and Nutrition.
Cervenka I; Al Rahmoun M; Mahamat-Saleh Y; Fournier A; Boutron-Ruault MC; Severi G; Caini S; Palli D; Ghiasvand R; Veierod MB; Botteri E; Tjønneland A; Olsen A; Fortner RT; Kaaks R; Schulze MB; Panico S; Trichopoulou A; Dessinioti C; Niforou K; Sieri S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Sandanger TM; Colorado-Yohar S; Sánchez MJ; Gil Majuelo L; Lujan-Barroso L; Ardanaz E; Merino S; Isaksson K; Butt S; Ljuslinder I; Jansson M; Travis RC; Khaw KT; Weiderpass E; Dossus L; Rinaldi S; Kvaskoff M
Int J Cancer; 2020 Jun; 146(12):3267-3280. PubMed ID: 31506954
[TBL] [Abstract][Full Text] [Related]
36. Is breast cancer risk the same for all progestogens?
Stute P
Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
[TBL] [Abstract][Full Text] [Related]
37. Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women's health initiative randomized controlled trial.
Tang JY; Fu T; Leblanc E; Manson JE; Feldman D; Linos E; Vitolins MZ; Zeitouni NC; Larson J; Stefanick ML
J Clin Oncol; 2011 Aug; 29(22):3078-84. PubMed ID: 21709199
[TBL] [Abstract][Full Text] [Related]
38. Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study.
Fornili M; Perduca V; Fournier A; Jérolon A; Boutron-Ruault MC; Maskarinec G; Severi G; Baglietto L
Breast Cancer Res; 2021 Apr; 23(1):47. PubMed ID: 33865453
[TBL] [Abstract][Full Text] [Related]
39. Associations of non-melanoma skin cancer and melanoma, extra-cutaneous cancers and smoking in adults: a US population-based study.
Silverberg JI; Ratner D
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1389-97. PubMed ID: 25491569
[TBL] [Abstract][Full Text] [Related]
40. Menopausal hormone therapies and risk of colorectal cancer: a Swedish matched-cohort study.
Liu Q; Simin J; Debelius J; Fall K; Sadr-Azodi O; Engstrand L; Williams C; Brusselaers N
Aliment Pharmacol Ther; 2021 Jun; 53(11):1216-1225. PubMed ID: 33857339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
